PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. Starting in 2026, the provision will affect 10 Part D drugs. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029.

Management 105

Management Manufacturing Sales Competition 105

Pharmaceutical Technology

JANUARY 16, 2023

The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

Healthcare Success

JANUARY 27, 2025

Focus on Health Over Lifestyle Be direct and prioritize information about coverage for physicians, prescriptions, and chronic health conditions over lifestyle-focused advertising. And so networks might be squeezed by this. Be Transparent About Costs Include clear cost breakdowns (e.g., And then hopefully some stability in the premiums.

Marketing 65

Marketing Education Media Leads 65